The nurse is setting up an intravenous infusion pump to administer a dose of vancomycin [Vancocin] to a patient. What is the fastest rate at which the drug may be infused?

A. Gentamicin: Gentamicin is an aminoglycoside antibiotic effective against many bacteria, but it's not the first choice for MRSA. Vancomycin or other alternatives are preferred due to the rising resistance of MRSA to gentamicin.

B. Nafcillin: Nafcillin is a penicillin antibiotic, often used for penicillin-sensitive staphylococcal infections. However, it is not effective against MRSA, which is resistant to many penicillin-based antibiotics.

C. Vancomycin: Vancomycin is a glycopeptide antibiotic used to treat a variety of bacterial infections, including MRSA. It works by inhibiting cell wall synthesis in bacteria, making it effective against Gram-positive bacteria that have developed resistance to other antibiotics like methicillin (which MRSA has).

D. Penicillin: Penicillin is a group of antibiotics that includes drugs like amoxicillin and ampicillin. MRSA is resistant to penicillin-based antibiotics, so they are not effective against MRSA infections.

A. Ototoxicity and Nephrotoxicity:
Ototoxicity: Aminoglycosides can damage the inner ear structures, leading to hearing loss and balance issues.
Nephrotoxicity: These drugs can harm the kidneys, potentially causing acute kidney injury or chronic kidney disease. Monitoring kidney function is crucial to prevent renal damage.

B. Ototoxicity and Cardiotoxicity:
Ototoxicity: As mentioned above, aminoglycosides can damage the inner ear, affecting hearing and balance.
Cardiotoxicity: Aminoglycosides primarily affect the ears and kidneys; they do not directly target the heart. Cardiotoxicity is not a common side effect associated with aminoglycosides.

C. Hepatotoxicity and Nephrotoxicity:
Hepatotoxicity: This term refers to liver damage caused by drugs or toxins. Aminoglycosides are not known to cause liver problems; their primary concern is kidney damage.
Nephrotoxicity: As mentioned earlier, aminoglycosides can harm the kidneys, which is a well-known side effect.

D. Cardiotoxicity and Hepatotoxicity:
Cardiotoxicity: This term refers to the toxic effects on the heart, leading to various heart-related issues. Aminoglycosides do not primarily affect the heart; their main concerns are the ears (ototoxicity) and kidneys (nephrotoxicity).
Hepatotoxicity: Aminoglycosides are not typically associated with liver damage. They are primarily metabolized and excreted by the kidneys, which is why kidney monitoring is crucial during their use.